不同细胞消化方式对靶向CD3L1的抗体结合肿瘤细胞的影响

张远, 邓守言, 许杰

PDF(1151 KB)
PDF(1151 KB)
复旦学报(医学版) ›› 2025, Vol. 52 ›› Issue (03) : 429-436. DOI: 10.3969/j.issn.1672-8467.2025.03.014
方法技术

不同细胞消化方式对靶向CD3L1的抗体结合肿瘤细胞的影响

作者信息 +

The impact of different cell digestion methods on the binding of an anti-CD3L1 antibody to tumor cells

Author information +
History +

摘要

目的 探讨不同的细胞消化方式对靶向CD3L1的人源化单克隆抗体(代号:5H)结合肿瘤细胞的影响。 方法 使用胰蛋白酶溶液或胶原酶与中性蛋白酶混合液,在室温和37 ℃两种消化温度下对不同贴壁肿瘤细胞系进行离解、传代和收集。随后,通过流式细胞术和共聚焦显微镜成像,比较不同消化条件下肿瘤细胞与5H抗体的结合差异。 结果 使用胰蛋白酶溶液在室温离解和传代的细胞仅表现出与5H抗体的微弱结合,而相同的细胞系用胶原酶与中性蛋白酶混合液在室温消化后,则显示出与5H抗体的明显结合,两组之间抗体结合信号及抗体染色阳性细胞比例的差异有统计学意义(P<0.01)。胶原酶与中性蛋白酶混合液处理的细胞与抗体的结合信号呈现出抗体浓度依赖性,可用于受体占位分析。相比室温,37 ℃的条件下消化后略微削弱了靶细胞与5H抗体的结合,但该差异无统计学意义。 结论 胰蛋白酶溶液消化方式显著削弱了抗CD3L1抗体与肿瘤细胞的结合,而胶原酶与中性蛋白酶混合液的消化方式能有效保护该结合。在选择适宜的消化酶处理细胞的前提下,消化温度的影响相对次要。在研究抗体药物与细胞表面抗原相互作用时,应采用合理且经过优化的细胞消化方案。

Abstract

Objective To investigate the impact of different cell digestion methods on the binding of a humanized monoclonal antibody targeting CD3L1 (designated as 5H) to tumor cells. Methods Trypsin solution and a collagenase/neutral protease cocktail, combined with two digestion temperatures (room temperature and 37°C), were used to dissociate, passage, and collect various adherent tumor cell lines. Flow cytometry and confocal microscopy were then employed to compare differences in 5H antibody binding under different cell digestion conditions. Results Cells dissociated and passaged with trypsin solution at room temperature exhibited only weak binding to the 5H antibody, whereas those treated with the collagenase/neutral protease cocktail at room temperature showed significantly stronger binding. There were notable differences in the binding signal and the proportion of antibody-stained positive cells between the two groups (P<0.01). Additionally, cells treated with the collagenase/neutral protease cocktail exhibited antibody binding signals that were dependent on the concentration of the 5H antibody, enabling receptor occupancy analysis. Compared to digestion at room temperature, treatment at 37°C resulted in a slight reduction in the binding of target cells to the 5H antibody, however, this difference was not statistically significant. Conclusion Trypsin digestion significantly reduces the binding of the anti-CD3L1 antibody to tumor cells, whereas the collagenase/neutral protease cocktail effectively preserves it. With an appropriate choice of digestion enzymes, the impact of digestion temperature is relatively minor. These findings suggest that optimized cell digestion protocols should be employed when studying interactions between antibody drugs and cell surface antigens.

关键词

CD3L1 / 胞膜蛋白 / 细胞消化 / 抗体-抗原结合 / 肿瘤免疫治疗

Key words

CD3L1 / cell membrane proteins / cell digestion / antibody-antigen binding / cancer immunotherapy

中图分类号

R730.3

引用本文

导出引用
张远 , 邓守言 , 许杰. 不同细胞消化方式对靶向CD3L1的抗体结合肿瘤细胞的影响. 复旦学报(医学版). 2025, 52(03): 429-436 https://doi.org/10.3969/j.issn.1672-8467.2025.03.014
ZHANG Yuan, DENG Shou-yan, XU Jie. The impact of different cell digestion methods on the binding of an anti-CD3L1 antibody to tumor cells[J]. Fudan University Journal of Medical Sciences. 2025, 52(03): 429-436 https://doi.org/10.3969/j.issn.1672-8467.2025.03.014

参考文献

1
DENG S ZHANG Y WANG H,et al.ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion[J].Cell2024187(9):2305-2333.
2
DENG S SHI J SUN Y,et al.Development of a monoclonal antibody to ITPRIPL1 for immunohistochemical diagnosis of non-small cell lung cancers:accuracy and correlation with CD8(+) T cell infiltration[J].Front Cell Dev Biol202311:1297211.
3
ARLINDO EM MARCONDES NA FERNANDES FB,et al.Quantitative flow cytometric evaluation of CD200,CD123,CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms[J].Rev Bras Hematol Hemoter201739(3):252-258.
4
DOGAN A SIEGEL D TRAN N,et al.B-cell maturation antigen expression across hematologic cancers:a systematic literature review[J].Blood Cancer J202010(6):73.
5
AUDIA A BANNISH G BUNTING R,et al.Flow cytometry and receptor occupancy in immune-oncology[J].Expert Opin Biol Ther202222(1):87-94.
6
HOSONUMA M HIRASAWA Y KURAMASU A,et al.Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit[J].Cancer Sci2024115(3):752-762.
7
ROBERS MB FRIEDMAN-OHANA R HUBER KVM,et al.Quantifying target occupancy of small molecules within living cells[J].Annu Rev Biochem202089:557-581.
8
CLISTER T,FEY RM, GARRISON ZR,et al.Optimization of tissue digestion methods for characterization of photoaged skin by single cell RNA sequencing reveals preferential enrichment of T cell subsets[J].Cells202413(3):266.
9
SHI W WANG Y ZHANG C,et al.Isolation and purification of immune cells from the liver[J].Int Immunopharmacol202085:106632.
10
MARKOSSIAN S GROSSMAN A ARKIN M,et al.Assay guidance manual[M].Bethesda (MD):Eli Lilly & Company and the National Center for Advancing Translational Sciences,2004.
11
QUAN Y YAN Y WANG X,et al.Impact of cell dissociation on identification of breast cancer stem cells[J].Cancer Biomark201212(3):125-133.
12
JUNKER F GULATI P WESSELS U,et al.A human receptor occupancy assay to measure anti-PD-1 binding in patients with prior anti-PD-1[J].Cytometry A202199(8):832-843.
13
DEAN AQ LUO S TWOMEY JD,et al.Targeting cancer with antibody-drug conjugates:promises and challenges[J].MAbs202113(1):1951427.
14
YAO H LAN J LI C,et al.Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours[J].Nat Biomed Eng20193(4):306-317.
15
PERRIGUE PM MURRAY RA MIELCAREK A,et al.Degradation of drug delivery nanocarriers and payload release:a review of physical methods for tracing nanocarrier biological fate[J].Pharmaceutics202113(6):770.
16
PEREZ BAY AE FAULKNER D DASILVA JO,et al.A bispecific METxMET antibody-drug conjugate with cleavable linker is processed in recycling and late endosomes[J].Mol Cancer Ther202322(3):357-370.
17
PERERA RM ZONCU R JOHNS TG,et al.Internalization,intracellular trafficking,and biodistribution of monoclonal antibody 806:a novel anti-epidermal growth factor receptor antibody[J].Neoplasia20079(12):1099-1110.
18
STEWART JJ GREEN CL JONES N,et al.Role of receptor occupancy assays by flow cytometry in drug development[J].Cytometry B Clin Cytom201690(2):110-116.
19
PANCHISION DM CHEN HL PISTOLLATO F,et al.Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133,CD15,and CD24[J].Stem Cells200725(6):1560-1570.
20
ZOLLER M.CD44:can a cancer-initiating cell profit from an abundantly expressed molecule?[J].Nat Rev Cancer201111(4):254-267.
21
TAKEDA M OGINO S UMEMOTO R,et al.Ligand-induced structural changes of the CD44 hyaluronan-binding domain revealed by NMR[J].J Biol Chem2006281(52):40089-40095.
22
LAI TY CAO J OU-YANG P,et al.Different methods of detaching adherent cells and their effects on the cell surface expression of Fas receptor and Fas ligand[J].Sci Rep202212(1):5713.
23
CHEN S,SO EC, STROME SE,et al.Impact of detachment methods on M2 macrophage phenotype and function[J].J Immunol Methods2015426:56-61.

作者贡献声明

张远 实验实施,数据采集和整理,论文撰写。邓守言 实验指导。许杰 实验设计和指导,论文修订。

基金

国家自然科学基金(82030104)

评论

PDF(1151 KB)

Accesses

Citation

Detail

段落导航
相关文章

/